D. Robinson

发表

Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.

D. Isenberg, H. Møller, M. Lazarus, 2006, Rheumatology.

Completeness of cancer registration: a new method for routine use

M. Coleman, J. Peto, J. Lutz, 2000, British Journal of Cancer.

Breast cancer survival in England, Norway and Sweden: a population‐based comparison

L. Holmberg, F. Bray, A. Purushotham, 2010, International journal of cancer.

A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study.

L. Holmberg, F. Bray, F. Hamdy, 2012, Cancer epidemiology.

Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study

J. Cuzick, S. Darby, H. Møller, 2007, BMC Cancer.

Population‐based study of long‐term functional outcomes after prostate cancer treatment

P. Stattin, P. Fransson, S. Loeb, 2015, BJU international.

Suicide in cancer patients in South East England from 1996 to 2005: a population-based study

H. Møller, D. Robinson, C. Renshaw, 2009, British Journal of Cancer.

The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ

L. Holmberg, H. Møller, D. Robinson, 2008, British Journal of Cancer.

A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004

L. Holmberg, F. Bray, L. Påhlman, 2011, Gut.

Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

P. Stattin, S. Loeb, D. Robinson, 2017, JAMA oncology.

Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study

P. Stattin, O. Akre, D. Robinson, 2014, PloS one.

Prescription-based prediction of baseline mortality risk among older men

P. Stattin, R. Gedeborg, H. Garmo, 2020, PloS one.

The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.

T. Powles, J. Shamash, T. Oliver, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population‐based study in Sweden

P. Stattin, H. Garmo, D. Robinson, 2020, BJU international.

Immediate versus delayed prostatectomy: Nationwide population-based study*

P. Stattin, D. Makarov, S. Loeb, 2016, Scandinavian journal of urology.

Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden

L. Holmberg, P. Stattin, J. Adolfsson, 2019, Scandinavian journal of urology.

Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden

L. Holmberg, P. Stattin, J. Adolfsson, 2012, International journal of cancer.

A visual summary of the EUROCARE-4 results: a UK perspective

H. Møller, D. Robinson, K. Linklater, 2009, British Journal of Cancer.

Evaluation of data quality in the National Prostate Cancer Register of Sweden.

P. Stattin, M. Lambe, D. Robinson, 2015, European journal of cancer.

Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110.

P. Stattin, M. Lambe, D. Robinson, 2015, European urology.

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study

P. Stattin, M. Lambe, D. Robinson, 2018, International journal of cancer.

Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors

G. Aus, E. Varenhorst, D. Robinson, 2007, Scandinavian journal of urology and nephrology.

Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort.

G. Aus, E. Varenhorst, D. Robinson, 2003, European urology.

Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.

R. Sankila, T. Hakulinen, H. Møller, 2007, European Journal of Cancer.

Second primary cancers in patients with squamous cell carcinoma of the skin

H. Møller, D. Robinson, C. Rowland-Payne, 2004, British Journal of Cancer.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

B. Gazzard, T. Powles, J. Shamash, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study

P. Stattin, E. Holmberg, M. Lambe, 2013, Cancer Causes & Control.

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide populationbased study

M. Lambe, D. Robinson, E. Ventimiglia, 2018 .

Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer Registry

L. Holmberg, A. Rodriguez-Vida, S. Chowdhury, 2013, BJU international.

Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

L. Holmberg, P. Stattin, A. Pettersson, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen.

L. Holmberg, P. Stattin, A. Pettersson, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates

L. Holmberg, H. Møller, D. Robinson, 2011, British Journal of Cancer.

Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis.

L. Holmberg, F. Bray, L. Påhlman, 2012, European journal of cancer.

Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England

C. Lewis, S. Hodgson, H. Møller, 2001, British Journal of Cancer.

Mortality and incidence of second cancers following treatment for testicular cancer

A. Horwich, H. Møller, D. Robinson, 2007, British Journal of Cancer.

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

M. Eklund, P. Stattin, J. Adolfsson, 2022, Scandinavian journal of urology.

Capture rate and representativity of The National Prostate Cancer Register of Sweden

P. Stattin, A. Berglund, M. Lambe, 2015, Acta oncologica.

Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

P. Stattin, M. Lambe, D. Robinson, 2018, Scandinavian journal of urology.

Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance

P. Stattin, S. Loeb, D. Robinson, 2019, The Journal of urology.

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

L. Holmberg, P. Stattin, H. Garmo, 2015, Cancer Causes & Control.

Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.

P. Stattin, T. Schlomm, S. Loeb, 2016, European urology.

Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

K. Michaëlsson, P. Stattin, H. Garmo, 2015, PloS one.

An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England

H. Møller, D. Robinson, V. Coupland, 2009, British Journal of Cancer.

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG‐4) study

L. Holmberg, P. Stattin, H. Garmo, 2018, BJU international.

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer

L. Holmberg, P. Stattin, S. Gudbjörnsdottir, 2016, International journal of cancer.

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

L. Holmberg, P. Stattin, H. Garmo, 2020, PloS one.

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

Mats Lambe, Hans Garmo, Henrik Møller, 2016, Cancer medicine.

Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden

P. Stattin, H. Garmo, D. Robinson, 2016, Acta oncologica.

Gleason inflation 1998–2011: a registry study of 97 168 men

P. Stattin, L. Egevad, D. Robinson, 2015, BJU international.

Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories

P. Stattin, A. Berglund, S. Loeb, 2014, Scandinavian journal of urology.

Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

L. Holmberg, P. Stattin, L. Mucci, 2013, BMJ.

Fatherhood status and risk of prostate cancer: Nationwide, population-based case–control study

P. Stattin, E. Holmberg, S. Carlsson, 2013, International journal of cancer.

Androgen deprivation therapy for prostate cancer and risk of dementia

L. Holmberg, P. Stattin, J. Adolfsson, 2019, BJU international.

PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer.

G. Aus, E. Varenhorst, P. O. Hedlund, 2008, Urology.

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus

L. Holmberg, A. Coolen, P. Stattin, 2018, International journal of cancer.

Opioid Use After Radical Prostatectomy: Nationwide, Population-Based Study in Sweden.

P. Stattin, S. Loeb, H. Garmo, 2019, The Journal of urology.

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

P. Stattin, H. Garmo, J. Damber, 2020, Acta oncologica.

The risk of subsequent primary cancers after colorectal cancer in southeast England

C. Lewis, S. Hodgson, H. Møller, 2002, Gut.

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.

P. Stattin, C. Ingvar, M. Lambe, 2015, JAMA.

Radiation-induced malignancies following radiotherapy for breast cancer

H. Møller, R. Roychoudhuri, D. Robinson, 2004, British Journal of Cancer.

Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study.

P. Stattin, J. Adolfsson, M. van Hemelrijck, 2017, European urology.

The National Prostate Cancer Register of Sweden

Pär Stattin, David Robinson, P. Stattin, 2017, Tijdschrift voor Urologie.

Management of women with early breast cancer

H. Møller, J. Bell, D. Robinson, 2000, BMJ : British Medical Journal.

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

L. Holmberg, P. Stattin, N. Hammar, 2018, Cancer Causes & Control.

Prognostic implications of 2005 Gleason grade modification. Population‐based study of biochemical recurrence following radical prostatectomy

P. Stattin, K. Brasso, L. Egevad, 2016, Journal of surgical oncology.

Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study.

P. Stattin, J. Adolfsson, A. Pettersson, 2017, European urology.

Platinum Priority – Prostate Cancer Prostate Cancer Death After Radiotherapy or Radical Prostatectomy : A Nationwide Population-based Observational Study

P. Stattin, J. Adolfsson, A. Pettersson, 2018 .

Completeness and timeliness: Cancer registries could/should improve their performance.

S. Rosso, J. Coebergh, V. Zadnik, 2015, European journal of cancer.

A 13-year follow-up of patients with breast cancer presenting to a District General Hospital breast unit in southeast England.

H. Møller, J. Bell, D. Robinson, 2006, Breast.

National comparisons of lung cancer survival in England, Norway and Sweden 2001–2004: differences occur early in follow-up

L. Holmberg, F. Bray, M. Peake, 2010, Thorax.

Quantifying differences in breast cancer survival between England and Norway.

Henrik Møller, Paul C Lambert, David Robinson, 2011, Cancer epidemiology.

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

L. Holmberg, P. Stattin, R. Gedeborg, 2022, BMC Medical Informatics and Decision Making.

Predictors of early death in female patients with breast cancer in the UK: a cohort study

L. Holmberg, H. Møller, D. Robinson, 2011, BMJ Open.

Long‐term adverse effects after retropubic and robot‐assisted radical prostatectomy. Nationwide, population‐based study

P. Stattin, S. Carlsson, D. Robinson, 2017, Journal of surgical oncology.

Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England

H. Møller, I. Basnett, D. Robinson, 2003, British Journal of Cancer.

Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.

L. Holmberg, P. Stattin, J. Adolfsson, 2012, European journal of cancer.

Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.

P. Stattin, E. Varenhorst, S. Mommsen, 2008, The Journal of urology.

Season of cancer diagnosis exerts distinct effects upon short‐ and long‐term survival

L. Holmberg, H. Møller, R. Roychoudhuri, 2009, International journal of cancer.

Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study

J. Eastham, P. Stattin, P. Nilsson, 2016, Scandinavian journal of urology.

Population‐based, nationwide registration of prostatectomies in Sweden

P. Stattin, J. Hugosson, S. Carlsson, 2019, Journal of surgical oncology.

Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.

L. Holmberg, P. Stattin, J. Adolfsson, 2019, European urology.

ProBio II: An adaptive and randomized multi-arm biomarker driven phase 2 study in men with castrate resistant prostate cancer (CRPC).

J. Lindberg, H. Grönberg, M. Eklund, 2018 .

Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study.

P. Stattin, H. Jonsson, H. Garmo, 2017, European urology.

Risk of malignant melanoma in men with prostate cancer: Nationwide, population‐based cohort study

P. Stattin, C. Ingvar, M. Lambe, 2016, International journal of cancer.

Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.

Pär Stattin, David Robinson, Lars Egevad, 2016, European urology.

Trends in the treatment of breast cancer in Southeast England following the introduction of national guidelines.

H. Møller, D. Robinson, E. Davies, 2006, Journal of public health.

Completeness of ascertainment by cancer registries: putting bounds on the number of missing cases.

David Robinson, Paul B S Silcocks, P. Silcocks, 2004, Journal of public health.

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

L. Holmberg, P. Stattin, N. Hammar, 2018, Cancer Causes & Control.

How to model temporal changes in comorbidity for cancer patients using prospective cohort data

David Robinson, Lars Lindhagen, Mieke Van Hemelrijck, 2015, BMC Medical Informatics and Decision Making.

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

F. Montorsi, A. Salonia, P. Stattin, 2019, Front. Med..

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

B. Delahunt, H. Samaratunga, L. Egevad, 2017, Pathology.

Survival in prostate carcinoma—Outcomes from a prospective, population‐based cohort of 8887 men with up to 15 years of follow‐up

David Robinson, Gabriel Sandblom, G. Aus, 2005, Cancer.

Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

P. Stattin, J. Adolfsson, J. Damber, 2018, Scandinavian journal of urology.

‘Second primary breast cancers following an initial diagnosis of cancer in one breast: a methodological issue’

D. Robinson, 2008, British Journal of Cancer.

Radiotherapy waiting times for women with breast cancer: a population-based cohort study

R. Sainsbury, H. Møller, D. Robinson, 2007, BMC Cancer.

Waiting times for radiotherapy: variation over time and between cancer networks in southeast England

H. Møller, D. Robinson, R. Jack, 2005, British Journal of Cancer.

Dashboard report on performance on select quality indicators to cancer care providers

Mats Lambe, Pär Stattin, David Robinson, 2016, Scandinavian journal of urology.

Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study

P. Stattin, E. Holmberg, M. Lambe, 2013, Cancer Causes & Control.

MP42-10 EXPANDING USE OF ACTIVE SURVEILLANCE: DATA FROM THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN

P. Stattin, S. Loeb, D. Robinson, 2015 .

PAPER 5-a reductase inhibitors , benign prostatic hyperplasia , and risk of male breast cancer

L. Holmberg, P. Stattin, H. Garmo, 2015 .

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

P. Stattin, H. Garmo, D. Robinson, 2022, PloS one.

Simulation modelling to validate the flow method for estimating completeness of case ascertainment by cancer registries.

David Robinson, Paul B S Silcocks, P. Silcocks, 2007, Journal of public health.

A modification to the flow method to estimate completeness in cancer registries with delayed registration.

David Robinson, Fabio Montanaro, Andrea Bordoni, 2006, Journal of public health.

5α-Reductase Inhibitors and Risk of Prostate Cancer Death.

P. Stattin, H. Garmo, D. Robinson, 2019, The Journal of urology.

Postoperative mortality 90 days after robot‐assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population‐based study

P. Stattin, A. Cole, S. Loeb, 2016, BJU international.

Multiple primary tumours following head and neck cancer in southern England during 1961–98

K. Warnakulasuriya, D. Robinson, H. Evans, 2003 .

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000–2012

Pär Stattin, David Robinson, Brett Delahunt, 2017, BJU international.